Ching‐Chuan Kuo

4.3k total citations
111 papers, 3.5k citations indexed

About

Ching‐Chuan Kuo is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Ching‐Chuan Kuo has authored 111 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Molecular Biology, 35 papers in Organic Chemistry and 17 papers in Oncology. Recurrent topics in Ching‐Chuan Kuo's work include Synthesis and biological activity (24 papers), Biological Activity of Diterpenoids and Biflavonoids (14 papers) and Natural product bioactivities and synthesis (10 papers). Ching‐Chuan Kuo is often cited by papers focused on Synthesis and biological activity (24 papers), Biological Activity of Diterpenoids and Biflavonoids (14 papers) and Natural product bioactivities and synthesis (10 papers). Ching‐Chuan Kuo collaborates with scholars based in Taiwan, United States and China. Ching‐Chuan Kuo's co-authors include Jang‐Yang Chang, Jing‐Ping Liou, Yueh‐Hsiung Kuo, Chi-Yen Chang, Wenchang Chiang, Hsing‐Pang Hsieh, Ming‐Chih Shih, Li‐Tzong Chen, Wen-Yu Pan and Su‐Ying Wu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The EMBO Journal.

In The Last Decade

Ching‐Chuan Kuo

108 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ching‐Chuan Kuo Taiwan 37 1.7k 1.1k 404 335 330 111 3.5k
Huiqing Yuan China 36 1.6k 1.0× 630 0.6× 341 0.8× 461 1.4× 506 1.5× 117 3.5k
Jih‐Hwa Guh Taiwan 40 2.7k 1.6× 1.0k 0.9× 611 1.5× 454 1.4× 646 2.0× 177 4.8k
Chunlin Zhuang China 33 2.4k 1.4× 1.7k 1.6× 519 1.3× 205 0.6× 239 0.7× 159 4.7k
Petr Džubák Czechia 28 2.1k 1.2× 960 0.9× 466 1.2× 285 0.9× 205 0.6× 157 3.5k
Sabrina Dallavalle Italy 32 2.1k 1.2× 1.3k 1.2× 632 1.6× 252 0.8× 138 0.4× 176 3.7k
Yoshihiro Uto Japan 31 1.3k 0.8× 474 0.4× 190 0.5× 292 0.9× 366 1.1× 161 3.3k
Rajesh N. Gacche India 29 987 0.6× 867 0.8× 324 0.8× 316 0.9× 285 0.9× 105 2.7k
Jian Huang China 29 1.6k 0.9× 575 0.5× 127 0.3× 396 1.2× 207 0.6× 139 2.8k
Maciej Czerwiński United States 15 1.9k 1.1× 898 0.8× 1.1k 2.7× 281 0.8× 405 1.2× 22 4.1k
Akiko Itai Japan 40 2.3k 1.3× 1.6k 1.5× 469 1.2× 203 0.6× 749 2.3× 173 4.9k

Countries citing papers authored by Ching‐Chuan Kuo

Since Specialization
Citations

This map shows the geographic impact of Ching‐Chuan Kuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching‐Chuan Kuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching‐Chuan Kuo more than expected).

Fields of papers citing papers by Ching‐Chuan Kuo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ching‐Chuan Kuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching‐Chuan Kuo. The network helps show where Ching‐Chuan Kuo may publish in the future.

Co-authorship network of co-authors of Ching‐Chuan Kuo

This figure shows the co-authorship network connecting the top 25 collaborators of Ching‐Chuan Kuo. A scholar is included among the top collaborators of Ching‐Chuan Kuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ching‐Chuan Kuo. Ching‐Chuan Kuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Ta-Wei, Ching‐Chuan Kuo, Yunhan Wang, et al.. (2025). Cytotoxicity-guided isolation of elatostemanosides I–VI from Elatostema tenuicaudatum W. T. Wang and their cytotoxic activities. RSC Advances. 15(14). 10639–10652. 2 indexed citations
3.
Li, Mu‐Chun, Limei Lin, Yi‐Ju Chen, et al.. (2025). KIF2C promotes paclitaxel resistance by depolymerizing polyglutamylated microtubules. Developmental Cell. 60(15). 2097–2113.e8.
4.
Lin, Chih‐Peng, Shuhui Wu, Tzu‐yin Lin, et al.. (2023). Lysosomal-targeted doxorubicin delivery using RBC-derived vesicles to overcome drug-resistant cancer through mitochondrial-dependent cell death. Pharmacological Research. 197. 106945–106945. 4 indexed citations
5.
Tsai, I‐Ting, Ching‐Chuan Kuo, Jing‐Ping Liou, & Jang‐Yang Chang. (2018). Novel microtubule inhibitor MPT0B098 inhibits hypoxia-induced epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma. Journal of Biomedical Science. 25(1). 28–28. 11 indexed citations
6.
Hou, Pei‐Chi, Shih‐Chieh Lin, Jenq-Chang Lee, et al.. (2017). Hypoxia-Induced Downregulation of DUSP-2 Phosphatase Drives Colon Cancer Stemness. Cancer Research. 77(16). 4305–4316. 54 indexed citations
7.
Yeh, Teng‐Kuang, Ching‐Chuan Kuo, Yue‐Zhi Lee, et al.. (2017). Design, Synthesis, and Evaluation of Thiazolidine-2,4-dione Derivatives as a Novel Class of Glutaminase Inhibitors. Journal of Medicinal Chemistry. 60(13). 5599–5612. 30 indexed citations
9.
Chang, C.S., Hsueh‐Yun Lee, Teng-Kuang Yeh, et al.. (2014). Antimitotic and vascular disrupting agents: 2-Hydroxy-3,4,5-trimethoxybenzophenones. European Journal of Medicinal Chemistry. 77. 306–314. 8 indexed citations
10.
Liou, Jing‐Ping, Ching‐Chuan Kuo, Chi-Yen Chang, et al.. (2013). MPT0B098, a Novel Microtubule Inhibitor That Destabilizes the Hypoxia-Inducible Factor-1α mRNA through Decreasing Nuclear–Cytoplasmic Translocation of RNA-Binding Protein HuR. Molecular Cancer Therapeutics. 12(7). 1202–1212. 32 indexed citations
11.
Kao, Yu‐Hsun, Jing‐Ping Liou, Gi‐Shih Lien, et al.. (2013). Histone deacetylase inhibition improved cardiac functions with direct antifibrotic activity in heart failure. International Journal of Cardiology. 168(4). 4178–4183. 82 indexed citations
12.
Huang, Cheng-Chih, Sen‐Tien Tsai, Ching‐Chuan Kuo, et al.. (2012). Arginine deprivation as a new treatment strategy for head and neck cancer. Oral Oncology. 48(12). 1227–1235. 32 indexed citations
14.
Lee, Hsueh‐Yun, Ching‐Chuan Kuo, Pen-Yuan Lin, et al.. (2012). Application of Suzuki arylation, Sonogashira ethynylation and Rosenmund–von Braun cyanation in the exploration of substitution effects on the anticancer activity of 2-aroylquinolines. Organic & Biomolecular Chemistry. 10(48). 9593–9593. 5 indexed citations
16.
Chen, Pi-Yu, Chin‐Hui Chen, Ching‐Chuan Kuo, et al.. (2011). Cytotoxic Steroidal Saponins fromAgave sisalana. Planta Medica. 77(9). 929–933. 39 indexed citations
17.
Kuo, Ching‐Chuan, et al.. (2007). Tamoxifen accelerates proteasomal degradation of O6‐methylguanine DNA methyltransferase in human cancer cells. International Journal of Cancer. 121(10). 2293–2300. 24 indexed citations
18.
Chiang, Yi‐Ming, Jang‐Yang Chang, Ching‐Chuan Kuo, Chi-Yen Chang, & Yueh‐Hsiung Kuo. (2005). Cytotoxic triterpenes from the aerial roots of Ficus microcarpa. Phytochemistry. 66(4). 495–501. 139 indexed citations
19.
Juang, Shin‐Hun, Wen-Yu Pan, Ching‐Chuan Kuo, et al.. (2004). A novel bis-benzylidenecyclopentanone derivative, BPR0Y007, inducing a rapid caspase activation involving upregulation of Fas (CD95/APO-1) and wild-type p53 in human oral epidermoid carcinoma cells. Biochemical Pharmacology. 68(2). 293–303. 14 indexed citations
20.
Kuo, Yueh‐Hsiung, Shih‐Chang Chien, & Ching‐Chuan Kuo. (2002). Antioxidative 7-Oxodehydropodocarpane-Type Trinorditerpenes from the Bark ofTaiwania cryptomerioides. Planta Medica. 68(11). 1020–1023. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026